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Background 
The National Institute for Health and Care Excellence (NICE) guidelines in 2016 recommend 
tuberculin skin test (TST) at a 5-mm induration size cut-off for latent tuberculosis infection 
(LTBI) screening of adult close contacts of active tuberculosis (TB) cases. An alternative 
would be to use an interferon-gamma release assay (IGRA) which has a higher specificity, 
such as the QuantiFERON-TB Gold in Tube (QFT-GIT) or T-SPOT.TB (T-SPOT). We 
aimed to evaluate the cost-effectiveness of the screening and treatment of LTBI in adult close 
contacts with various combinations of these tests in a representative London cohort.     
Methods 
Clinical data of adult close contacts of pulmonary TB cases who were recommended to 
receive TST and IGRA in a TB clinic in London between 2008 and 2010 were retrospectively 
reviewed. A Markov decision analytic model, using an NHS perspective and lifetime horizon, 
was used to compare costs and quality-adjusted life-years (QALYs) associated with 7 
screening strategies followed by chemoprophylaxis: TST alone, IGRA (QFT-GIT or T-
SPOT) alone, TST positive followed by IGRA, and TST negative followed by IGRA. Future 
costs and QALYs were discounted at 3.5% per year. 
Results 
381 asymptomatic close contacts aged 18 to 65 years were included in this study. The mean 
age was 35.2 years and the majority (75.3%) were BCG vaccinated. In the base-case analysis, 
QFT-GIT was the most cost-effective strategy with £6,876 per QALY gained, compared to 
TST positive followed by QFT-GIT strategy. QFT-GIT alone averted 1.8 TB cases per 1,000 
contacts compared to TST positive followed by QFT-GIT.  
Conclusion 
Of the considered testing strategies, the QFT-GIT alone is preferable for LTBI screening in 
adult close contacts of pulmonary TB cases in London.  
 
